Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Tumor Ablation Market Insights
3.1. Tumor ablation– Industry snapshot
3.2. Tumor ablation -Ecosystem analysis
3.3. Tumor ablation market dynamics
3.3.1. Tumor ablation– Market Forces
3.3.1.1. Tumor ablation Market driver analysis
3.3.1.2. Tumor ablation Market restraint/challenges analysis
3.3.1.3. Tumor ablation Market opportunity analysis
3.3.2. Industry analysis - Porter's five force
3.3.2.1. Bargaining power of supplier
3.3.2.2. Bargaining power of buyer
3.3.2.3. Threat of substitute
3.3.2.4. Threat of new entrant
3.3.2.5. Degree of competition
3.3.3. Tumor ablation market PEST analysis, 2017
3.3.4. Value Chain Analysis
3.3.5. Tumor ablation Industry trends
3.3.6. Prevalence of tumor ablation 
4. Tumor ablation Market Size and Forecast by type of technology
4.1. Key findings
4.2. Radiofrequency (RF) ablation
4.2.1. Global market estimates and forecasts, 2017 – 2025
4.3. Microwave ablation
4.3.1. Global market estimates and forecasts, 2017 – 2025
4.4. Cryoablation
4.4.1. Global market estimates and forecasts, 2017 – 2025
4.5. Others
4.5.1. Global market estimates and forecasts, 2017 – 2025
5. Tumor ablation Market Size and Forecast by Mode of treatment
5.1. Key findings
5.2. Surgical ablation
5.2.1. Global market estimates and forecasts, 2017 – 2025
5.3. Laparoscopic ablation
5.3.1. Global market estimates and forecasts, 2017 – 2025
5.4. Percutaneous ablation
5.4.1. Global market estimates and forecasts, 2017 – 2025
6. Tumor ablation Market Size and Forecast by Application
6.1. Key findings
6.2. Liver cancer
6.2.1. Global market estimates and forecasts, 2017 – 2025
6.3. Lung cancer
6.3.1. Global market estimates and forecasts, 2017 – 2025
6.4. Kidney cancer
6.4.1. Global market estimates and forecasts, 2017 – 2025
6.5. Bone metastasis
6.5.1. Global market estimates and forecasts, 2017 – 2025
6.6. Others
6.6.1. Global market estimates and forecasts, 2017 – 2025
7. Tumor ablation Market Size and Forecast by Regions
7.1. Key findings
7.2. North America
7.2.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.2.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.2.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.2.4. U.S.
7.2.4.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.2.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.2.4.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.2.5. Canada
7.2.5.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.2.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.2.5.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.3. Europe
7.3.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.3.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.3.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.3.4. Germany
7.3.4.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.3.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.3.4.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.3.5. UK
7.3.5.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.3.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.3.5.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.4. Asia Pacific
7.4.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.4.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.4.4. China
7.4.4.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.4.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.4.4.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.4.5. India
7.4.5.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.4.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.4.5.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.4.6. Japan
7.4.6.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.4.6.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.4.6.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.5. Latin America
7.5.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.5.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.5.4. Brazil
7.5.4.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.5.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.5.4.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.5.5. Mexico
7.5.5.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.5.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.5.5.3. Tumor ablation Market by application (USD Million), 2017 - 2025
7.6. Middle East & Africa
7.6.1. Tumor ablation Market by Type of Technology (USD Million), 2017 - 2025
7.6.2. Tumor ablation Market by Mode of treatment (USD Million), 2017 - 2025
7.6.3. Tumor ablation Market by application (USD Million), 2017 - 2025
8. Company Profiles
8.1. EDAP TMS S.A.
8.1.1. Overview
8.1.2. Financials
8.1.3. Product Type Benchmarking
8.1.4. Recent Developments
8.2. Jude Medical Inc.
8.2.1. Overview
8.2.2. Financials
8.2.3. Product Type Benchmarking
8.2.4. Recent Developments
8.3. BVM Medical Ltd.
8.3.1. Overview
8.3.2. Financials
8.3.3. Product Type Benchmarking
8.3.4. Recent Developments
8.4. SonaCare Medical LLC
8.4.1. Overview
8.4.2. Financials
8.4.3. Product Type Benchmarking
8.4.4. Recent Developments
8.5. AngioDynamics Inc.
8.5.1. Overview
8.5.2. Financials
8.5.3. Product Type Benchmarking
8.5.4. Recent Developments
8.6. Boston Scientific Corp.
8.6.1. Overview
8.6.2. Financials
8.6.3. Product Type Benchmarking
8.6.4. Recent Developments
8.7. Pacific Biosciences of California, Inc
8.7.1. Overview
8.7.2. Financials
8.7.3. Product Type Benchmarking
8.7.4. Recent Developments
8.8. BTG International Ltd.
8.8.1. Overview
8.8.2. Financials
8.8.3. Product Type Benchmarking
8.8.4. Recent Developments
8.9. Integra Life Sciences Holdings Corp.
8.9.1. Overview
8.9.2. Financials
8.9.3. Product Type Benchmarking
8.10. Medtronic plc.
8.10.1. Overview
8.10.2. Financials
8.10.3. Product Type Benchmarking
8.10.4. Recent Developments